Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2002 Dec;87(6):457–461. doi: 10.1136/adc.87.6.457

Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom

G Todd 1, C Acerini 1, R Ross-Russell 1, S Zahra 1, J Warner 1, D McCance 1
PMCID: PMC1755820  PMID: 12456538

Abstract

Background: Until recently, only two cases of acute adrenal crisis associated with inhaled corticosteroids (ICS) had been reported worldwide. We identified four additional cases and sought to survey the frequency of this side effect in the United Kingdom.

Methods: Questionnaires were sent to all consultant paediatricians and adult endocrinologists registered in a UK medical directory, asking whether they had encountered asthmatic patients with acute adrenal crisis associated with ICS. Those responding positively completed a more detailed questionnaire. Diagnosis was confirmed by symptoms/signs and abnormal hypothalamic-pituitary-adrenal axis function test results.

Results: From an initial 2912 questionnaires, 33 patients met the diagnostic criteria (28 children, five adults). Twenty-three children had acute hypoglycaemia (13 with decreased levels of consciousness or coma; nine with coma and convulsions; one with coma, convulsions and death); five had insidious onset of symptoms. Four adults had insidious onset of symptoms; one had hypoglycaemia and convulsions. Of the 33 patients treated with 500–2000 µg/day ICS, 30 (91%) had received fluticasone, one (3%) fluticasone and budesonide, and two (6%) beclomethasone.

Conclusions: The frequency of acute adrenal crisis was greater than expected as the majority of these patients were treated with ICS doses supported by British Guidelines on Asthma Management. Despite being the least prescribed and most recently introduced ICS, fluticasone was associated with 94% of the cases. We therefore advise that the licensed dosage of fluticasone for children, 400 µg/day, should not be exceeded unless the patient is being supervised by a physician with experience in problematic asthma. We would also emphasise that until adrenal function has been assessed patients receiving high dose ICS should not have this therapy abruptly terminated as this could precipitate adrenal crisis.

Full Text

The Full Text of this article is available as a PDF (116.0 KB).

Figure 1 .

Figure 1

Open in a new tab

Percentage of prescriptions in the UK compared with percentage of cases of acute adrenal crisis reported in a UK survey.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berend N., Kellett B., Kent N., Sly P. D., Collaborative Study Group of the Australian Lung Foundation Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate. Respirology. 2001 Sep;6(3):237–246. doi: 10.1046/j.1440-1843.2001.00329.x. [DOI] [PubMed] [Google Scholar]
  2. Broide J., Soferman R., Kivity S., Golander A., Dickstein G., Spirer Z., Weisman Y. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab. 1995 Apr;80(4):1243–1246. doi: 10.1210/jcem.80.4.7714095. [DOI] [PubMed] [Google Scholar]
  3. Casale T. B., Nelson H. S., Stricker W. E., Raff H., Newman K. B. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol. 2001 Nov;87(5):379–385. doi: 10.1016/S1081-1206(10)62918-3. [DOI] [PubMed] [Google Scholar]
  4. Chang A. B., Asher M. I. A review of cough in children. J Asthma. 2001 Jun;38(4):299–309. doi: 10.1081/jas-100002296. [DOI] [PubMed] [Google Scholar]
  5. Crowley S., Hindmarsh P. C., Holownia P., Honour J. W., Brook C. G. The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol. 1991 Sep;130(3):475–479. doi: 10.1677/joe.0.1300475. [DOI] [PubMed] [Google Scholar]
  6. Drake A. J., Howells R. J., Shield J. P. H., Prendiville A., Ward P. S., Crowne E. C. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ. 2002 May 4;324(7345):1081–1082. doi: 10.1136/bmj.324.7345.1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eid Nemr, Morton Ronald, Olds Bradley, Clark Pamela, Sheikh Shahid, Looney Stephen. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics. 2002 Feb;109(2):217–221. doi: 10.1542/peds.109.2.217. [DOI] [PubMed] [Google Scholar]
  8. Fabbri L., Burge P. S., Croonenborgh L., Warlies F., Weeke B., Ciaccia A., Parker C. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax. 1993 Aug;48(8):817–823. doi: 10.1136/thx.48.8.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fuller R., Johnson M., Bye A. Fluticasone propionate--an update on preclinical and clinical experience. Respir Med. 1995 Sep;89 (Suppl A):3–18. doi: 10.1016/0954-6111(95)90259-7. [DOI] [PubMed] [Google Scholar]
  10. Harrison T. W., Wisniewski A., Honour J., Tattersfield A. E. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax. 2001 Mar;56(3):186–191. doi: 10.1136/thorax.56.3.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hindmarsh Peter. Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult. BMJ. 2002 May 4;324(7345):1083–1083. [PubMed] [Google Scholar]
  12. Holt S., Suder A., Weatherall M., Cheng S., Shirtcliffe P., Beasley R. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ. 2001 Aug 4;323(7307):253–256. doi: 10.1136/bmj.323.7307.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Howarth P. H. Why particle size should affect clinical response to inhaled therapy. J Aerosol Med. 2001;14 (Suppl 1):S27–S34. doi: 10.1089/08942680150506312. [DOI] [PubMed] [Google Scholar]
  14. Jarvis B., Faulds D. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma. Drugs. 1999 May;57(5):769–803. doi: 10.2165/00003495-199957050-00016. [DOI] [PubMed] [Google Scholar]
  15. Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol. 1996 Jan;97(1 Pt 2):169–176. doi: 10.1016/s0091-6749(96)80217-x. [DOI] [PubMed] [Google Scholar]
  16. Lipworth B. J., Jackson C. M. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf. 2000 Jul;23(1):11–33. doi: 10.2165/00002018-200023010-00002. [DOI] [PubMed] [Google Scholar]
  17. Lipworth B. J. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. 1999 May 10;159(9):941–955. doi: 10.1001/archinte.159.9.941. [DOI] [PubMed] [Google Scholar]
  18. McKenzie S. Cough--but is it asthma? Arch Dis Child. 1994 Jan;70(1):1–2. doi: 10.1136/adc.70.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Olsson B. Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers? J Aerosol Med. 1995 Sep;8 (Suppl 3):S13–S19. doi: 10.1089/jam.1995.8.suppl_3.s-13. [DOI] [PubMed] [Google Scholar]
  20. Patel L., Wales J. K., Kibirige M. S., Massarano A. A., Couriel J. M., Clayton P. E. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child. 2001 Oct;85(4):330–334. doi: 10.1136/adc.85.4.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pedersen S., O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy. 1997;52(39 Suppl):1–34. doi: 10.1111/j.1398-9995.1997.tb05047.x. [DOI] [PubMed] [Google Scholar]
  22. Ryrfeldt A., Andersson P., Edsbäcker S., Tönnesson M., Davies D., Pauwels R. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis Suppl. 1982;122:86–95. [PubMed] [Google Scholar]
  23. Thorsson L., Dahlström K., Edsbäcker S., Källén A., Paulson J., Wirén J. E. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol. 1997 Feb;43(2):155–161. doi: 10.1046/j.1365-2125.1997.d01-1425.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Todd G. R., Wright D., Ryan M. Acute adrenal insufficiency in a patient with asthma after changing from fluticasone propionate to budesonide. J Allergy Clin Immunol. 1999 May;103(5 Pt 1):956–957. doi: 10.1016/s0091-6749(99)70447-1. [DOI] [PubMed] [Google Scholar]
  25. Todd G., Dunlop K., McNaboe J., Ryan M. F., Carson D., Shields M. D. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet. 1996 Jul 6;348(9019):27–29. doi: 10.1016/s0140-6736(96)03339-9. [DOI] [PubMed] [Google Scholar]
  26. Tønnesen P. How to reduce smoking among teenagers. Eur Respir J. 2002 Jan;19(1):1–3. doi: 10.1183/09031936.02.00280802. [DOI] [PubMed] [Google Scholar]
  27. Wilson A. M., Dempsey O. J., Coutie W. J., Sims E. J., Lipworth B. J. Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids. Lancet. 1999 Jun 19;353(9170):2128–2128. doi: 10.1016/S0140-6736(99)01443-9. [DOI] [PubMed] [Google Scholar]
  28. Wong J. Y. W., Zacharin M. R., Hocking N., Robinson P. J. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate. J Paediatr Child Health. 2002 Feb;38(1):59–62. doi: 10.1046/j.1440-1754.2002.00717.x. [DOI] [PubMed] [Google Scholar]
  29. Wong J., Black P. Acute adrenal insufficiency associated with high dose inhaled steroids. BMJ. 1992 May 30;304(6839):1415–1415. doi: 10.1136/bmj.304.6839.1415-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Zwaan C. M., Odink R. J., Delemarre-van de Waal H. A., Dankert-Roelse J. E., Bokma J. A. Acute adrenal insufficiency after discontinuation of inhaled corticosteroid therapy. Lancet. 1992 Nov 21;340(8830):1289–1290. doi: 10.1016/0140-6736(92)92991-n. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES